‘Legal highs’ may be more dangerous than traditional drugs of abuse
Novel psychoactive substances (NPS), or "legal highs," have had various definitions but can simply be...
Health News 2 me
healthnews2me.com
Category: Medications
Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
DUBLIN, Ireland and CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM),...
Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting
NEWTON, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical...
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease
CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology...
New US survey shows some progress against opioid crisis
Figures from a U.S. government survey released Friday show some progress in the fight against...
Highest opioid-related mortality seen in construction jobs
(HealthDay)—Proportional mortality ratios (PMRs) for heroin-related overdose deaths and methadone-related overdose deaths from 2007 to...
Recalled blood pressure drugs not linked to increased short term cancer risk
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased...
New Yorkers who use drugs report changing behaviors to avoid overdose
People who use drugs in New York City have adjusted their behaviors to avoid overdose,...
Naloxone rarely administered by layperson in opioid deaths
(HealthDay)—From July 2016 to June 2017, bystanders were documented in 44 percent of opioid overdose...
Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Sep. 6, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) and Galapagos...